Wells Fargo & Company Champions Oncology, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 47 shares of CSBR stock, worth $237. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47
Previous 46
2.17%
Holding current value
$237
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CSBR
# of Institutions
28Shares Held
5.66MCall Options Held
2.6KPut Options Held
9.2K-
Battery Management Corp. Boston, MA2.42MShares$12.2 Million2.62% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$8.65 Million0.59% of portfolio
-
Tocqueville Asset Management L.P. New York, NY685KShares$3.46 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny125KShares$629,6890.0% of portfolio
-
Black Rock Inc. New York, NY116KShares$584,1990.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $68.3M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...